Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Name:	us-gaap_UnsecuredDebt
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Loan from Related Parties (Details Narrative) - USD ($)		3 Months Ended	9 Months Ended
Loan from Related Parties (Details Narrative) - USD ($)	Jan. 31, 2017	Apr. 30, 2017	Apr. 30, 2017	Apr. 30, 2016	Apr. 27, 2017	Jan. 16, 2017
Paid to Emmaus Life Sciences, Inc						$ 500,000
Retirement of debt					$ 658,622
Increase in loan payable			$ 982,122
Moscato
Unsecured advance		$ 75,820	75,820			250,000
Salvo
Unsecured advance		82,803	82,803			$ 250,000
Hema Diagnostic Systems, LLC
Outstanding balance		13,549,241	$ 13,549,241
Increase in loan payable	$ 68,000	$ 241,404